Phase I/II of Roche PNH candidate temporarily halted

Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) said enrollment was temporarily stopped in the international Phase I/II COMPOSER trial evaluating

Read the full 182 word article

User Sign In